Acumen Pharmaceuticals Inc
ABOS1.350USD
0.000
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
81.77MMarket Cap
LossP/E TTM
Acumen Pharmaceuticals Inc
1.350
0.000
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-91.06%-34.12M
-227.34%-27.21M
-90.59%-24.60M
-41.77%-16.55M
-75.52%-17.86M
25.79%-8.31M
-40.53%-12.90M
-80.43%-11.67M
-22.61%-10.18M
-207.86%-11.20M
-19.45%-9.18M
-51.69%-6.47M
-250.17%-8.30M
-27.37%-3.64M
-499.22%-7.69M
-185.41%-4.26M
-30.51%-2.37M
---2.86M
---1.28M
---1.49M
---1.82M
Net income from continuing operations
-93.61%-28.80M
-125.22%-37.15M
-129.72%-29.77M
-76.89%-20.54M
-31.54%-14.87M
-28.22%-16.50M
-20.98%-12.96M
-14.37%-11.61M
-23.86%-11.31M
-54.10%-12.87M
-174.47%-10.71M
83.46%-10.15M
66.19%-9.13M
-1005.83%-8.35M
-56.71%-3.90M
-2915.14%-61.36M
-1220.15%-27.00M
---755.00K
---2.49M
---2.04M
---2.04M
Operating gains losses
2.27%45.00K
12.82%44.00K
12.50%45.00K
-15.09%45.00K
-15.38%44.00K
-20.41%39.00K
-9.09%40.00K
35.90%53.00K
40.54%52.00K
1533.33%49.00K
4300.00%44.00K
--39.00K
--37.00K
--3.00K
--1.00K
----
----
----
----
----
----
Other non-cash items
80.67%-289.00K
86.67%-119.00K
-21.55%-863.00K
-296.00%-1.19M
-347.60%-1.50M
-914.77%-893.00K
-471.73%-710.00K
-278.57%-300.00K
-254.63%-334.00K
-136.21%-88.00K
809.52%191.00K
--168.00K
--216.00K
--243.00K
--21.00K
----
----
----
----
----
----
Change in working capital
-81.02%-7.36M
35.79%8.22M
525.28%3.73M
382.23%3.77M
-17045.83%-4.07M
643.73%6.05M
-294.25%-878.00K
-148.32%-1.33M
158.54%24.00K
-80.01%814.00K
111.06%452.00K
383.76%2.76M
-103.19%-41.00K
362.03%4.07M
-449.74%-4.08M
-293.44%-973.00K
575.79%1.28M
---1.55M
--1.17M
--503.00K
--190.00K
-Change in receivables
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
100.00%0.00
-100.00%0.00
100.00%0.00
--108.00K
---217.00K
--256.00K
---226.00K
-Change in prepaid expenses
520.35%950.00K
705.97%540.00K
-156.51%-846.00K
-202.13%-3.12M
74.86%-226.00K
118.72%67.00K
222.30%1.50M
-155.41%-1.03M
-163.49%-899.00K
-186.06%-358.00K
61.62%-1.22M
275.38%1.87M
3318.18%1.42M
201.96%416.00K
-5898.18%-3.19M
-786.45%-1.06M
-117.53%-44.00K
---408.00K
--55.00K
--155.00K
--251.00K
-Change in other current assets
-54.29%16.00K
171.88%23.00K
205.26%58.00K
-223.08%-42.00K
179.55%35.00K
45.76%-32.00K
35.71%19.00K
51.85%-13.00K
32.31%-44.00K
-5800.00%-59.00K
--14.00K
---27.00K
-400.00%-65.00K
-100.19%-1.00K
100.00%0.00
-100.00%0.00
95.53%-13.00K
--522.00K
---108.00K
--21.00K
---291.00K
-Change in other current liabilities
100.00%0.00
-100.00%0.00
--0.00
--0.00
---23.00K
--17.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Cash from non-recurring investing activities
Cash from operating activities
-91.06%-34.12M
-227.34%-27.21M
-90.59%-24.60M
-41.77%-16.55M
-75.52%-17.86M
25.79%-8.31M
-40.53%-12.90M
-80.43%-11.67M
-22.61%-10.18M
-207.86%-11.20M
-19.45%-9.18M
-51.69%-6.47M
-250.17%-8.30M
-27.37%-3.64M
-499.22%-7.69M
-185.41%-4.26M
-30.51%-2.37M
---2.86M
---1.28M
---1.49M
---1.82M
Investing cash flow
Net cash from continuing investing activities
618.18%79.00K
-100.00%0.00
-100.00%0.00
--5.00K
--11.00K
-60.00%14.00K
-91.36%7.00K
-100.00%0.00
-100.00%0.00
34.62%35.00K
912.50%81.00K
500.00%36.00K
--9.00K
--26.00K
--8.00K
--6.00K
----
----
--0.00
--0.00
----
Capital expenditures
618.18%79.00K
-100.00%0.00
-100.00%0.00
--5.00K
--11.00K
-60.00%14.00K
-91.36%7.00K
-100.00%0.00
-100.00%0.00
34.62%35.00K
912.50%81.00K
500.00%36.00K
--9.00K
--26.00K
--8.00K
--6.00K
----
----
--0.00
--0.00
----
Net cash flow from disposal of fixed assets
618.18%79.00K
-100.00%0.00
-100.00%0.00
--5.00K
--11.00K
-60.00%14.00K
-91.36%7.00K
-100.00%0.00
-100.00%0.00
34.62%35.00K
912.50%81.00K
500.00%36.00K
--9.00K
--26.00K
--8.00K
--6.00K
----
----
--0.00
--0.00
----
Net cash flow from investment products
412.97%28.77M
160.79%29.66M
88.99%-10.13M
240.78%37.70M
78.08%-9.19M
-139.36%-48.79M
-264.28%-92.00M
25.43%11.06M
-723.71%-41.93M
-104.16%-20.39M
159.51%56.00M
--8.82M
---5.09M
---9.98M
---94.09M
----
----
----
----
----
----
Net cash flow from other investing activities
----
----
----
----
----
----
--3.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
411.74%28.69M
160.78%29.66M
88.99%-10.13M
240.74%37.70M
78.05%-9.20M
-139.02%-48.81M
-264.53%-92.00M
25.94%11.06M
-722.26%-41.93M
-103.98%-20.42M
159.42%55.92M
146516.67%8.79M
---5.10M
---10.01M
---94.10M
---6.00K
----
----
--0.00
--0.00
----
Financing cash flow
Cash flow from continuous financing activities
-100.51%-36.00K
-100.03%-9.00K
-100.03%-42.00K
11.72%-128.00K
--7.11M
596.32%29.13M
46778.33%122.76M
-935.71%-145.00K
----
41740.00%4.18M
-100.16%-263.00K
-100.04%-14.00K
----
-99.98%10.00K
--168.78M
--31.68M
--0.00
--44.67M
--0.00
--0.00
--0.00
Net cash flow from debt Issuance/repayment
----
-100.00%0.00
--0.00
----
----
--30.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net cash flow from common stock issuance/repurchase
-100.92%-73.00K
97.69%-9.00K
-100.00%0.00
--0.00
--7.91M
-110.28%-390.00K
--122.29M
----
----
126500.00%3.79M
----
----
----
---3.00K
--168.56M
----
----
----
----
----
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
----
-100.00%0.00
--0.00
--30.03M
--0.00
--44.67M
--0.00
--0.00
--0.00
Proceeds from stock option exercised by employees
--37.00K
--0.00
----
----
----
-100.00%0.00
16150.00%325.00K
----
----
638.46%96.00K
100.33%2.00K
-97.23%17.00K
----
--13.00K
---612.00K
--614.00K
--0.00
--0.00
--0.00
--0.00
--0.00
Proceeds from issuance of warrants
----
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
----
--0.00
--614.00K
--1.25M
----
----
--0.00
--0.00
----
Net cash flow from other financing activities
100.00%0.00
100.00%0.00
-128.97%-42.00K
11.72%-128.00K
---799.00K
-260.81%-476.00K
154.72%145.00K
-367.74%-145.00K
----
--296.00K
-220.45%-265.00K
85.91%-31.00K
----
----
--220.00K
---220.00K
----
----
----
--0.00
----
Net cash from non-recurrent financing activities
Net cash from financing activities
-100.51%-36.00K
-100.03%-9.00K
-100.03%-42.00K
11.72%-128.00K
--7.11M
596.32%29.13M
46778.33%122.76M
-935.71%-145.00K
----
41740.00%4.18M
-100.16%-263.00K
-100.04%-14.00K
----
-99.98%10.00K
--168.78M
--31.68M
--0.00
--44.67M
--0.00
--0.00
--0.00
Net cash flow
Beginning cash balance
-46.57%35.86M
-64.86%33.42M
-11.73%68.19M
-39.53%47.16M
-48.41%67.12M
-39.63%95.11M
-30.45%77.25M
-28.29%78.00M
6.50%130.10M
16.01%157.54M
61.41%111.07M
162.67%108.76M
179.06%122.16M
6832.21%135.80M
2022.52%68.81M
774.30%41.41M
568.15%43.78M
--1.96M
--3.24M
--4.74M
--6.55M
Current period cash flow changes
72.60%-5.47M
108.71%2.44M
-294.70%-34.77M
2899.73%21.03M
61.70%-19.95M
-2.00%-27.99M
-61.57%17.86M
-132.61%-751.00K
-288.88%-52.10M
-101.17%-27.44M
-30.63%46.47M
-91.60%2.30M
-465.32%-13.40M
-132.62%-13.64M
5321.36%66.99M
1934.34%27.41M
-30.51%-2.37M
--41.82M
---1.28M
---1.49M
---1.82M
Ending cash balance
-35.56%30.39M
-46.57%35.86M
-64.86%33.42M
-11.73%68.19M
-39.53%47.16M
-48.41%67.12M
-39.63%95.11M
-30.45%77.25M
-28.29%78.00M
6.50%130.10M
16.01%157.54M
61.41%111.07M
162.67%108.76M
179.06%122.16M
6832.21%135.80M
2022.52%68.81M
774.30%41.41M
--43.78M
--1.96M
--3.24M
--4.74M
Free cash flow
-91.38%-34.20M
-226.79%-27.21M
-90.49%-24.60M
-41.82%-16.55M
-75.63%-17.87M
25.89%-8.33M
-39.38%-12.91M
-79.43%-11.67M
-22.47%-10.18M
-206.63%-11.24M
-20.37%-9.26M
-52.32%-6.50M
---8.31M
---3.67M
-499.84%-7.70M
-185.81%-4.27M
----
----
---1.28M
---1.49M
----
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
